[ 2 ] Siitonen SM, Kononen JT, Helin HJ, et al. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer[J]. Am J Clin Pathol, 1996, 105(4): 394-402.
[3]
[ 3 ] Maguire TM, Shering SG, Mcdermott EW, et al. Assay of E-cadherin by ELISA in human breast cancers[J]. Eur J Cancer, 1997, 33(3): 404-408.
[ 5 ] Kamai T, Takagi K, Asami H, et al. Decreasing of p27 (kip1) and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer[J]. Br J Cancer, 2001, 84(9): 1242-1251.
[6]
[ 6 ] Zbar AP, Simopoulos C, Karayiannakis AJ. Cadherins: an integral role in inflammatory bowel disease and mucosal restitution[J]. J Gastroenterol, 2004, 39(5): 413-421.
[7]
[ 7 ] Bornman DM, Mathew S, Alsruhe J, et al. Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals[J]. Am J Pathol, 2001, 159(3): 831-835.
[8]
[ 8 ] Omran OM. CD10 and E-Cad expression in urinary bladder urothelial and squamous cell carcinoma[J]. J Environ Pathol Toxicol Oncol, 2012, 31(3): 203-212.
[9]
[ 9 ] Sun GY, Wu JX, Wu JS, et al. Caveolin-1, E-cadherin and β-catenin in gastric carcinoma, precancerous tissues and chronic non-atrophic gastritis[J]. Chin J Cancer Res, 2012, 24(1): 23-28.
[10]
Wei Y, Lukashev M, Simon DI, et al. Regulation of integrin function by the urokinase receptor[J]. Science, 1996, 273(5281): 1551-1555.
Jiang JT, Zhang LF, Zhou B, et al. Relationships of uPA and VEGF expression in esophageal cancer and microvascular density with tumorous invasion and metastasis[J]. Asian Pac J Cancer Prev, 2012, 13(7): 3379-3383
